Pesquisa

Edição
Título
Autores
Nº 7 (2023)
Comparative analysis of the effectiveness of programs and perinatal outcomes after frozen-thawed embryo transfer depending on post-transfer support medications
Bashmakova N., Lokshin V., Isenova S., Khramtsova A., Dankova I., Ryabukhin I.
PDF
(Rus)
Nº 9 (2023)
Therapeutic equivalence evaluation of bioequivalent and original micronized vaginal progesterone preparations in hormone replacement therapy in women undergoing frozen-thawed embryo transfer
Bashmakova N., Khramtsova A., Dzhalilova E.
PDF
(Rus)
Nº 4 (2015)
POSSIBILITIES FOR REDUCING THE RISK OF PRETERM BIRTH IN THE CONTEXT OF EVIDENCE-BASED MEDICINE
Aganezov S., Aganezova N.
PDF
(Rus)
Nº 8 (2020)
Changes in the clinical symptoms of fibrocystic mastopathy during monotherapy with transdermal micronized progesterone: results of the BREAST-2 multicenter open prospective cohort study
Protasova A.
PDF
(Rus)
Nº 7 (2017)
Placental PIBF1 gene mRNA expression during preterm labor
Dobrokhotova Y., Trofimov D., Shchegolev A., Burmenskaya O., Veselovskaya Y., Mitrofanova Y., Olenev A., Pastarnak A., Gogichaev T.
PDF
(Rus)
Nº 1 (2014)
Current approaches to luteal phase management in an in-vitro fertilization program
Gallyamova E., Perminova S., Durinyan E., Mityurina E.
PDF
(Rus)
Nº 2 (2019)
Use of micronized progesterone in the prevention and therapy of miscarriage
Ignatko I., Strizhakov A., Kuznetsov A., Churganova A., Lebedev V., Bogacheva N., Bogomazova I., Kardanov M.
PDF
(Rus)
Nº 12 (2016)
EFFICACY OF MICRONIZED PROGESTERONE-CONTAINING TRANSDERMAL GEL IN THE TREATMENT OF FIBROCYSTIC MASTOPATHY: RESULTS OF A RUSSIAN STUDY
Andreeva E., Rozhkova N.
PDF
(Rus)
Nº 10 (2013)
NEW POSSIBILITIES FOR THE TREATMENT OF ENDOMETRIAL HYPERPLASIA WITH NATURAL MICRONIZED PROGESTERONE
CHERNUKHA G., DUMANOVSKAYA M., KOGAN E., ASATUROVA A., FAIZULLINA N.
PDF
(Rus)
Nº 11 (2018)
Dynamics of clinical symptoms of fibrocystic breast disease in the course of the transdermal gel of micronized progesterone monotherapy: results of the Russian multicenter observational study BREAST
Protasova A., Andreyeva E., Rozhkova N., Vandeyeva E.
PDF
(Rus)
Nº 5 (2016)
EVALUATION OF THE EFFICIENCY OF HEMOSTATIC THERAPY WITH MICRONIZED PROGESTERONE FOR ABNORMAL UTERINE BLEEDING
Balan V., Tikhomirova E.
PDF
(Rus)
Nº 3 (2013)
EFFICIENCY OF PREVENTION OF PREMATURE BIRTH
SEROV V., SUKHORUKOVA O.
PDF
(Rus)
Nº 8 (2018)
OUTCOMES OF THE SECOND HALF OF PREGNANCY IN PATIENTS WITH RECURRENT PREGNANCY LOSS (RESULTS OF MULTICENTER STUDY OF TRISTAN-2)
SAVELEVA G., AKSENENKO V., ANDREEVA M., BAZINA M., BASHMAKOVA N., BOROVKOVA L., BRYUHINA E., BUSHTYIREVA I., VOLKOV V., GUREV1O D., DANKOVA I., DOBROHOTOVA Y., EGOROVA A., IVANOVA T., KONSTANTINOVA O., KOROTKIH I., KRAVCHENKO E., KRAMARSKIY V., KULESHOV V., LEBEDENKO E., MALTSEVA L., MANUHIN I., MARTIROSYAN S., MIHELSON A., OLINA2O A., PASHOV A., ROGOZHINA I., SAHAUTDINOVA I., SELIHOVA M., SEROVA O., SINCHIHIN S., SICHINAVA L., TAPILSKAYA N., TSHAY V., YARMOLINSKAYA M.
PDF
(Rus)
Nº 7 (2015)
Impact of luteal-phase support with a GnRH agonist on the outcomes of IVF programs
Gallyamova E., Perminova S., Mityurina E., Strelchenko D.
PDF
(Rus)
Nº 7-1 (2011)
THE VAGINAL BIOCENOSIS IN THE USE OF MICRONIZED PROGESTERONE
VORONTSOVA A., ZVYCHAINYI M.
PDF
(Rus)
Nº 10 (2018)
Opportunities for using gonadotropin-releasing hormone agonist for luteal phase support in the in vitro fertilization program
Perminova S., Mityurina E., Savelyeva E.
PDF
(Rus)
Nº 5 (2015)
EXPERIENCE WITH MICRONIZED PROGESTERONE THERAPY FOR MISCARRIAGE IN PREGNANT WOMEN WITH UTERINE MYOMA
Iashchuk A., Dautova L., Shevchenko Y., Naftulovich R., Tyurina A., Murzin V.
PDF
(Rus)
Nº 5 (2018)
Comparative evaluation of efficacy and safety of micronized progesterone in assisted reproductive technology programs
Malyshkina A., Nazarov S., Semenenko S., Kozelkova E.
PDF
(Rus)
Nº 11 (2017)
Micronized progesterone therapy of recurrent pregnancy loss (results of multicenter TRISTAN-1 study)
Saveleva G., Aksenenko V., Andreeva M., Bazina M., Bashmakova N., Borovkova L., Bryuhina E., Bushtyireva I., Volkov V., Gurev D., Dankova I., Dobrohotova Y., Egorova A., Ivanova T., Konstantinova O., Korotkih I., Kravchenko E., Kramarskiy V., Kuleshov V., Lebedenko E., Maltseva L., Manuhin I., Martirosyan S., Mihelson A., Olina A., Pashov A., Rogozhina I., Sahautdinova I., Selihova M., Serova O., Sinchihin S., Sichinava L., Tapilskaya N., Tshay V., Yarmolinskaya M.
PDF
(Rus)
Nº 5 (2015)
OPTIMIZATION OF MENOPAUSAL HORMONE THERAPY-RELATED RISKS: MONOTHERAPY WITH TRANSDERMAL ESTROGENS OR IN COMBINATION WITH MICRONIZED PROGESTERONE. ADVANTAGES AGAINST VENOUS THROMBOEMBOLISM AND BREAST CANCER
Yureneva S.
PDF
(Rus)
Nº 7 (2021)
Experience with micronized progesterone in obstetric practice
Khodzhaeva Z., Klimenchenko N., Muminova K., Gorina K., Frankevich V.
PDF
(Rus)
Nº 7 (2017)
Lotus I: A Phase III randomized controlled trial of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization, with focus on the Russian subpopulation
Sukhikh G., Baranov I., Melnichenko G., Bashmakova N., Blockeel C., Griesinger G., Lomakina A., Pexman-Fieth C.
PDF
(Rus)
Nº 6 (2015)
OPTIMIZATION OF MENOPAUSAL HORMONE THERAPY-RELATED RISKS: THERAPY WITH TRANSDERMAL ESTROGENS ALONE OR IN COMBINATION WITH MICRONIZED PROGESTERONE. ADVANTAGES AGAINST METABOLIC RISKS AND ARTERIAL THROMBOSIS
Yureneva S.
PDF
(Rus)
1 - 23 de 23 resultados
Dicas:
  • Palavras-chave são sensíveis a maiúsculas
  • Preposições e conjunções ingleses são ignoradas
  • Busca é feita por todos os palavras-chave (agente AND experimentador) por omissão
  • Use OR para pesquisar um termo exato, ex.: educação OR formação
  • Use parênteses para criar frases complexas, ex.: arquivo de ((revistas OR conferências) NOT teses)
  • Para pesquisar uma frase precisa use aspas duplas, ex.: "investigações científicas"
  • Exclua uma palavra utilizando o sinal - (hífen) ou operador NOT; ex.: concurso-de beleza ou concurso NOT de beleza
  • Use * como caractere-coringa, ex.: científic* recuperará as palavras "científico", "científicos", etc.

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies